Supplemental measles vaccine antibody response among HIV-infected and -uninfected children in Malawi...
Supplemental measles vaccine antibody response among HIV-infected and -uninfected children in Malawi after 1- and 2-dose primary measles vaccination schedules
About this item
Full title
Author / Creator
Publisher
Netherlands: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Netherlands: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Highlights • We evaluate antibody response to supplemental measles vaccine after an early vaccine schedule. • Early MV receipt does not interfere with sMV antibody responses. • Previous MV non-responders demonstrated sustained antibody titers. • HIV-infected children continued to demonstrate poor MV antibody response. • sMV is safe and effective fo...
Alternative Titles
Full title
Supplemental measles vaccine antibody response among HIV-infected and -uninfected children in Malawi after 1- and 2-dose primary measles vaccination schedules
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5737013
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5737013
Other Identifiers
ISSN
0264-410X
E-ISSN
1873-2518
DOI
10.1016/j.vaccine.2016.01.055
